SEC Form 4 · accession 0001602064-17-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Director
Period of report
Jan 19, 2017
Accepted (ET)
Jan 20, 2017 · 1:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $4.85 | Jan 19, 2017 | A | 9,500 | A | Jan 19, 2017 | Jan 18, 2027 | Common Stock | 9,500 | 9,500 | D |